Sunshine Biopharma, Inc - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE & CHIEF FINANCIAL OFFICER - March 30, 2011

Attached files

file filename
10-K - FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2010 - Sunshine Biopharma, Incfm10k_12-10.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Sunshine Biopharma, Incexh31-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Sunshine Biopharma, Incexh31-2.htm
EX-21.2 - LIST OF SUBSIDIARIES - Sunshine Biopharma, Incexh21-2.htm


Exhibit 32.1

CERTIFICATION PURSUANT TO
18 USC, SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this annual report of Sunshine Biopharma, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, the undersigned, in the capacities and on the date indicated below, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 
1.
The Report fully complies with the requirements of Rule 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:  March 30, 2011
s/Steve N. Slilaty
Steve N. Slilaty, Chief Executive Officer
   
Dated:  March 30, 2011
s/Camille Sebaaly
Camille Sebaaly, Chief Financial Officer



Sunshine Biopharma, Inc Reports